TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.700
+0.050 (1.37%)
At close: Aug 13, 2025, 4:00 PM
3.950
+0.250 (6.76%)
After-hours: Aug 13, 2025, 4:10 PM EDT

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
197153222313309-
Market Cap Growth
37.55%-31.30%-29.05%1.52%--
Enterprise Value
204165203351--
Last Close Price
3.955.018.4510.039.88-
PS Ratio
3.175.1912.0125.2836.75-
PB Ratio
--5.90-8.22-25.439.99-
EV/Sales Ratio
5.675.6010.9528.32--
Debt / Equity Ratio
-1.73-0.91-0.06-0.16--0.84
Asset Turnover
0.981.210.800.410.37-
Inventory Turnover
1.521.251.301.631.28-
Quick Ratio
3.441.331.040.344.970.09
Current Ratio
4.092.021.420.535.510.11
Return on Equity (ROE)
----507.96%--
Return on Assets (ROA)
-52.51%-93.08%-134.61%-76.13%-65.35%-
Return on Capital (ROIC)
-301.29%---221.74%-131.01%-
Earnings Yield
-17.35%-19.67%-26.70%-15.05%-9.34%-
FCF Yield
-14.85%-26.96%-23.01%-10.52%-7.71%-
Buyback Yield / Dilution
-37.59%-169.61%-2934.71%96.51%-15.52%-
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q